Wntresearch Ab
🇩🇰Denmark
- Country
- 🇩🇰Denmark
- Ownership
- Public
- Established
- 2007-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.wntresearch.com
Foxy-5 as Neo-Adjuvant Therapy in Subjects With Wnt-5a Low Colon Cancer
Phase 2
Active, not recruiting
- Conditions
- Colon Cancer
- Interventions
- First Posted Date
- 2019-03-21
- Last Posted Date
- 2022-12-09
- Lead Sponsor
- WntResearch AB
- Target Recruit Count
- 100
- Registration Number
- NCT03883802
- Locations
- 🇪🇸
Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain
Dose Escalating Study of Foxy-5 in Breast-, Colon- or Prostate Cancer Patients
Phase 1
Completed
- Conditions
- Metastatic Breast CancerMetastatic Colon CancerMetastatic Prostate Cancer
- Interventions
- First Posted Date
- 2016-01-14
- Last Posted Date
- 2018-12-28
- Lead Sponsor
- WntResearch AB
- Target Recruit Count
- 17
- Registration Number
- NCT02655952
- Locations
- 🇬🇧
NCCC, Freeman Hospital, Newcastle, Newcastle Upon Tyne, United Kingdom
🇩🇰Odense University Hospital, Odense, Denmark
🇩🇰Clinical Research Department, Oncology, Rigshospitalet, Copenhagen, Denmark
Phase I Study to Evaluate Safety, Tolerability, Anti-Tumour Activity and PK Profiles of Foxy-5 in Metastatic Breast, Colon or Prostate Cancer
Phase 1
Completed
- Conditions
- Colorectal CancerProstate CancerMetastatic Breast Cancer
- Interventions
- First Posted Date
- 2013-12-24
- Last Posted Date
- 2016-02-02
- Lead Sponsor
- WntResearch AB
- Target Recruit Count
- 31
- Registration Number
- NCT02020291
- Locations
- 🇩🇰
Oncology Department, Herlev Hospital, Herlev, Denmark
© Copyright 2025. All Rights Reserved by MedPath